Idexx Laboratories, Inc. (IDXX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt IDXX? Forum Prognose Aktiensplit

Warum fällt Idexx Laboratories, Inc.-Aktie (IDXX)?

Wir haben während der Handelssitzung 2024-05-01 einen Rückgang der Aktie Idexx Laboratories, Inc. (IDXX) um 5.02% festgestellt. Obwohl dies auf normale Volatilität oder verschiedene interne und externe Faktoren zurückzuführen sein kann, beachten Sie bitte, dass wir die Situation aktiv beobachten und so schnell wie möglich zeitnahe Updates bereitstellen!

2023-11-01:

Idexx Laboratories, Inc. Stock (IDXX) dropped by 1.03% from $399.47 to $395.35 in the trading on Wednesday November 01, 2023. The reasons why IDXX stock down today include:

Q3 financial results: Idexx posted Q3 earnings per share of $2.53, which beat estimates by 16 cents. Revenue increased nearly 9% Y/Y to $916 million, but misses expectations by $11.31 million. It is due to a relative slow down in wellness visits in the quarter, which may reflect some macro impacts on demand at the clinic level.
Full year revenue guidance: Idexx revised its full year revenue guidance to $3.635 - $3.65 billion from a previous forecast of $3.66 - $3.715 billion. The consensus revenue estimate is $3.68 billion. The organic growth guidance assumes a level of continued pressure on U.S. same-store clinical visits and International same-store sales levels in Q4 reflecting ongoing clinic capacity management dynamics and macro-economic impacts on demand.